Kilter Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Kilter Group's BMY Position: Q2 2026 in Review
Kilter Group increased its Bristol-Myers Squibb (BMY) stake by 9.6% in Q2 2026, buying an estimated $3.04K and bringing the position to 605 shares worth $34.9K. The position accounts for 0.01% of the portfolio, ranked #181.
Kilter Group first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Kilter Group held 605 shares of Bristol-Myers Squibb worth $34.9K as of Q2 2026.
- Kilter Group bought 53 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.04K.
- Bristol-Myers Squibb made up 0.01% of Kilter Group's portfolio in Q2 2026, its #181 holding.
- Kilter Group first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.